Fasken Martineau DuMoulin LLP

Offices

Canada
1. Calgary AB
  
  3400 First Canadian Centre, 350 - Seventh Avenue SW, Calgary AB T2P 3N9, Canada T 1 403 261 5350 F 1 403 261 5351 calgary@fasken.com
2. Montreal QC
  
  Stock Exchange Tower PO Box 242 37th Floor, 800 Victoria Square, Montreal QC H4Z 1E9, Canada T 1 514 397 7400 F 1 514 397 7600 montreal@fasken.com
3. Ottawa ON
  
  Suite 1300, 55 Metcalfe Street, Ottawa ON K1P 6L5, Canada T 1 613 236 3882 F 1 613 230 6423 ottawa@fasken.com
4. Quebec QC
  
  140 Grande Allee East, Suite 800, Quebec QC G1R 5M8, Canada T 1 418 640 2000 F 1 418 647 2455 quebec@fasken.com
5. Toronto ON
  
  333 Bay Street, Suite 2400, Bay Adelaide Centre, Box 20, Toronto ON M5H 2T6, Canada T 1 416 366 8381 F 1 416 364 7813 toronto@fasken.com
6. Vancouver BC
  
  2900-550 Burrard Street, Vancouver BC V6C 0A3, Canada T 1 604 631 3131 F 1 604 631 3232 vancouver@fasken.com
England
1. London Fasken Martineau LLP
  
  17 Hanover Square, London W1S 1HU, England T 44 20 7917 8500 F 44 20 7917 8555 W www.fasken.co.uk london@fasken.co.uk
France
1. Paris
  
  32 avenue de l’Opéra, Paris 75002, France T 33 1 44 94 96 98 F 33 1 44 94 96 99 paris@fasken.com
South Africa
1. Johannesburg
  
  Inanda Greens, Building 2, 54 Wierda Road West, Sandton, Johannesburg 2146, South Africa T 27 11 586 6000 F 27 11 586 6104 johannesburg@fasken.com

Progressive discipline required - even in harassment cases
Canada - June 12 2013
A long service costume designer was dismissed following a workplace harassment investigation. The employer also banned the guilty employee from all
After reconsideration, the Viagra patent is not void
Canada - June 11 2013
Close to seven months after rendering its decision in Teva Canada Ltd v Pfizer Canada Inc., 2012 SCC 60, the Supreme Court of Canada varied its
Amendments to TSX Venture Exchange Policy 4.4. Incentive Stock Options
Canada - June 7 2013
On May 8, 2013, the TSX Venture Exchange (TSXV) implemented amendments to Policy 4.4 - Incentive Stock Options (Policy 4.4). The amendments are
Canada preparing to impose retaliatory duties on U.S. imports
Canada - June 12 2013
On Friday, June 7, 2013, Canada's Ministers of International Trade and of Agriculture and Agrifood, released a list of U.S. commodities that are
More on prospectus marketing rule changes
Canada - June 13 2013
As reported in our Timely Disclosure post, on May 30, 2013, the Canadian Securities Administrators (CSA) published amendments to National Instrument

See more articles

Isolated human genes are no longer patentable in the United States
USA - June 17 2013
The United States Supreme Court has released its much anticipated decision in the case of Association for Molecular Pathology v. Myriad Genetics, Inc
The UK Takeover Panel extends the scope of its jurisdiction to all UK companies listed on aim or the ISDX Growth Market
United Kingdom - June 17 2013
On 15 May 2013, the UK Panel on Takeovers and Mergers (the "Panel") published a statement confirming that the UK Takeover Code (the "Takeover Code"
Changes to NI 31-103 cost disclosure and performance reports
Canada - June 14 2013
The Canadian Securities Administrators (CSA) have now implemented amendments to National Instrument 31-103 Registration Requirements Exemptions and
SEC provides guidance on conflict minerals and resource extraction disclosure requirements
Canada, USA - June 14 2013
The U.S. Securities and Exchange Commission (SEC) has issued fresh guidance for issuers on the requirements for compliance with the SEC's new
Ontario enacts anti-SLAPP legislation: The Ontario Protection of Public Participation Act, 2013
Canada - June 13 2013
The Ontario government has addressed the issue of 'SLAPP' lawsuits by introducing the Protection of Public Participation Act, 2013 (the "PPPA") in

See more articles